Pharmacists’ Roles in MM Management

Author(s):

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA,Amir Ali, PharmD, BCOP

Key Takeaways

Pharmacists are integral in developing and implementing order sets and clinical pathways in electronic health record systems, ensuring evidence-based care for multiple myeloma patients.
They collaborate with healthcare teams to optimize medication management, monitor patient responses, and manage side effects, enhancing treatment outcomes.
Pharmacists' expertise in pharmacotherapy and patient education improves treatment adherence and overall patient care quality.
Their integration into the healthcare team streamlines processes and contributes to the comprehensive management of multiple myeloma.

Panelists discuss how pharmacists play a crucial role throughout the multiple myeloma patient journey, from diagnosis to treatment, by contributing to medication management, patient education, adverse effect monitoring, and the development and implementation of order sets and clinical pathways within electronic medical record systems, thereby enhancing treatment efficacy and patient safety.

EP: 1.Treatment Landscape for Transplant-Eligible Patients with NDMM

EP: 2.Frontline Treatment and Sequencing Therapy

EP: 3.Impact of Transplant Eligibility on Treatment Selection

EP: 4.Treatment Regimen Considerations

EP: 5.Impact of IFM 2009 and DETERMINATION Studies

EP: 6.Key End Points in Clinical Trials

EP: 7.Real-World Considerations for New Therapies

EP: 8.Challenges in Adopting Novel Therapies

EP: 9.Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7

EP: 10.Impact of SC Daratumumab

EP: 11.SC vs IV Administration Methods

Now Viewing

EP: 12.Pharmacists’ Roles in MM Management

Video content above is prompted by the following:

How do pharmacists contribute to the patient journey and overall management of multiple myeloma from diagnosis through treatment?
(Dr Ali) What role do pharmacists play in developing and implementing order sets and clinical pathways within electronic medical record/electronic health record systems?